NCT04034719

Brief Summary

Carrying (or kangaroo carrying) is known to reduce neonatal and child morbidity and mortality and improves the quality of survival of premature and term children during the most fragile growth period, the first thousand days of life. Carrying is also a growing brain protection technique and becomes a routine of care in all neonatal units around the world. In University hospital of Saint-Etienne, the developmental care program has been developed since 2002 in all neonatology units and advocates the practice of skin-to-skin carrying between the parent (father or mother) and his baby, from the time of the hospitalization. Professionals in units who have long been thinking about the concept of attachment and the benefits of skin-to-skin, wish to validate the use of the wearing scarf as a tool for the practice of skin -in-skin in neonatology then back home by performing a randomized monocentric prospective longitudinal study.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 23, 2019

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 26, 2019

Completed
2 months until next milestone

Study Start

First participant enrolled

October 8, 2019

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 18, 2021

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 22, 2022

Completed
Last Updated

August 24, 2022

Status Verified

January 1, 2022

Enrollment Period

2 years

First QC Date

July 23, 2019

Last Update Submit

August 23, 2022

Conditions

Keywords

NewbornParentsCarryingSkin-to-skinScarf

Outcome Measures

Primary Outcomes (1)

  • Number of minuts with portage skin-to-skin

    Measured in minutes by the time sheet of presence.

    From inclusion to 2 months after exit

Study Arms (2)

Experimental group

EXPERIMENTAL

Newborn hospitalized in the neonatal department with their parent will be included. They will have a portage scarf to help them to keep their child skin-to-skin

Other: portage scarf

Control group

ACTIVE COMPARATOR

Newborn hospitalized in the neonatal department with their parent will be included. They wont have a portage scarf.

Other: usual practice

Interventions

Parents will be carried their newborn with the portage scarf provided by the department.

Experimental group

Parents will be carried their newborn as their usual practice.

Control group

Eligibility Criteria

AgeUp to 10 Weeks
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • For the child:
  • Any newborn regardless of gestational age and postnatal age hospitalized in the neonatology department of the University Hospital of Saint-Etienne
  • For the parent (father or mother):
  • Be a parent of a child eligible for the research protocol

You may not qualify if:

  • For the child:
  • Need for sedation or analgesia for the duration of the study
  • Orthopedic pathology incompatible with the practice of carrying
  • Other medical contraindications to carriage
  • Absence of parents
  • For the parent (father or mother):
  • Family, social or psychological situation compromising the evaluation
  • No fluency in the French language

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU Saint-Etienne

Saint-Etienne, France

Location

MeSH Terms

Conditions

Disease

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Hugues PATURAL, MD PhD

    CHU SAINT-ETIENNE

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 23, 2019

First Posted

July 26, 2019

Study Start

October 8, 2019

Primary Completion

October 18, 2021

Study Completion

March 22, 2022

Last Updated

August 24, 2022

Record last verified: 2022-01

Data Sharing

IPD Sharing
Will not share

Locations